Nj_resources

Addiction Treatment Resources in New Jersey: A Regional Guide

By NJ Addiction Centers Editorial Team | Last reviewed: | 23 min read Clinically Reviewed

New Jersey has one of the most developed addiction treatment infrastructures on the East Coast, shaped by decades of response to successive drug epidemics — from heroin in the 1970s through the crack era to the current opioid and fentanyl crisis. The state’s Division of Mental Health and Addiction Services (DMHAS), operating under the Department of Human Services, oversees licensing for treatment facilities, funds county-based treatment systems, and administers state and federal grants for substance use services. According to the NJ Department of Health, opioid-related overdose deaths in New Jersey exceeded 3,000 annually in recent years, making the state one of the hardest-hit in the nation on a per-capita basis. This guide provides a structured overview of New Jersey’s treatment landscape — organized by region, resource type, and special population — to help residents, families, and referring providers navigate the system.

Key Takeaways

  • New Jersey’s addiction treatment system is organized through DMHAS at the state level and administered through 21 county-based behavioral health systems.
  • NJ has treatment facilities across the full ASAM continuum of care, from medically managed detoxification through outpatient and aftercare services.
  • The NJ Addictions Hotline (1-844-276-2777) provides free, confidential referrals to treatment. NJ 2-1-1 connects residents to local social services including substance use treatment.
  • NJ involuntary commitment for substance use treatment operates under NJSA 30:4-27.2 — a process distinct from Florida’s Marchman Act or other states’ civil commitment laws.
  • NJ Medicaid (NJ FamilyCare) covers substance use disorder treatment including detoxification, residential, outpatient, and medication-assisted treatment.
  • Veterans in New Jersey have access to VA addiction treatment services, NJ-specific veteran programs, and community-based veteran service organizations.

How NJ Organizes Addiction Treatment

Understanding New Jersey’s treatment infrastructure requires knowing who oversees what and how the system is structured.

State-Level Oversight

The Division of Mental Health and Addiction Services (DMHAS) is the primary state agency responsible for addiction treatment in New Jersey. DMHAS functions include:

  • Licensing and monitoring treatment facilities (residential, outpatient, detoxification, and medication-assisted treatment programs)
  • Administering the federal Substance Abuse Prevention and Treatment Block Grant (SABG) from SAMHSA
  • Operating the state’s addiction treatment hotline and referral system
  • Setting standards for clinical practice in licensed facilities
  • Funding county-based treatment initiatives

The NJ Department of Health handles overdose surveillance, harm reduction programs (including naloxone distribution), and public health data reporting. The Department of Health operates the NJ Overdose Prevention Dashboard, which provides real-time and retrospective data on overdose incidents by county.

County-Based Systems

New Jersey’s 21 counties each have a designated behavioral health agency or board that coordinates publicly funded treatment services at the local level. These county systems serve as the entry point for residents who lack insurance or whose insurance does not cover the full cost of treatment. County systems can:

  • Conduct clinical assessments to determine appropriate level of care
  • Authorize placement in state-funded treatment programs
  • Connect individuals to detoxification, residential, and outpatient services
  • Provide referrals to medication-assisted treatment (MAT) providers

For individuals unsure where to start, the county behavioral health system is the recommended first point of contact for publicly funded treatment. The NJ Department of Human Services maintains a directory of county agencies.

The NJ treatment system can be navigated through several entry points:

  • NJ Addictions Hotline: 1-844-276-2777 — free, confidential assessment and referral, operated by the state
  • NJ 2-1-1 — dial 211 from any phone in New Jersey for connections to local health and human services, including substance use treatment
  • SAMHSA National Helpline: 1-800-662-4357 — federal referral service with NJ-specific treatment locator capabilities
  • 988 Suicide and Crisis Lifeline — for substance use crises involving suicidal ideation or acute psychiatric emergency
  • Emergency departments — NJ hospitals are increasingly implementing SBIRT (Screening, Brief Intervention, and Referral to Treatment) protocols in emergency departments, which means ED visits related to substance use now more frequently result in treatment referrals

Drug Rehab by NJ Region

Treatment availability and specialization vary across New Jersey’s geographic regions. The state’s population density, health system capacity, and demographic makeup differ substantially from the urban northeast (Newark, Jersey City) to the rural northwest (Sussex, Warren counties) to the southern counties bordering Philadelphia.

Newark and Essex County

Newark has the largest concentration of treatment facilities in the state, reflecting both the city’s population and the historical burden of substance use disorders in the community. Essex County has state-funded residential programs, outpatient clinics, methadone maintenance programs, and multiple buprenorphine prescribers. The VA New Jersey Health Care System’s East Orange campus serves veterans in this region.

For facility-level detail, see: Drug Rehab in Newark.

North Jersey (Bergen, Passaic, Hudson, Morris, Union)

North Jersey’s suburban and urban mix provides a range of treatment options. Bergen County has several private residential treatment facilities. Hudson County (Jersey City, Hoboken) has expanded treatment access in response to rising overdose rates. Morris County has invested in drug court programs and treatment alternatives to incarceration.

For regional coverage, see: Drug Rehab in North Jersey.

Central Jersey (Middlesex, Monmouth, Mercer, Somerset, Hunterdon)

Central Jersey facilities serve a geographically dispersed population. Monmouth County has been particularly affected by opioid-related overdose deaths and has responded with expanded treatment programming and naloxone distribution. Mercer County (Trenton) has state-level treatment resources given its role as the capital.

For regional coverage, see: Drug Rehab in Central Jersey.

South Jersey (Camden, Burlington, Gloucester, Atlantic, Cape May, Cumberland, Salem)

South Jersey’s treatment landscape is closely connected to the Philadelphia metropolitan area, with many residents crossing state lines for treatment. Camden County has seen significant investment in community-based treatment. Atlantic County (Atlantic City) faces particular challenges related to the hospitality industry, seasonal employment, and homelessness.

For regional coverage, see: Drug Rehab in South Jersey.

Northwest NJ (Sussex, Warren, Hunterdon)

New Jersey’s most rural counties face treatment access challenges common to rural areas nationwide: fewer facilities, longer travel distances, limited public transportation, and workforce shortages in behavioral health. Telehealth has expanded access somewhat, particularly for outpatient therapy and medication management.

For regional coverage, see: Drug Rehab in Northwest NJ.

The Jersey Shore (Ocean, Monmouth, Atlantic)

Shore communities face unique addiction dynamics tied to seasonal population fluctuations, tourism economies, and the well-documented history of opioid proliferation in Ocean County in particular. Ocean County has received national attention for its overdose rates and has responded with expanded treatment capacity and the development of the Ocean County Drug Court.

For regional coverage, see: Drug Rehab in the Shore Area.

Luxury and Specialized Rehab in NJ

New Jersey hosts a number of private-pay and insurance-based treatment programs that operate at a higher amenity level than standard residential treatment. These programs are commonly marketed as “luxury rehab” or “executive rehab.”

What these programs typically offer beyond standard residential treatment:

  • Private or semi-private rooms in residential settings
  • Lower patient-to-staff ratios
  • Expanded therapeutic options (equine therapy, acupuncture, fitness programming, nutritional counseling)
  • Accommodations for professionals who need to continue working during treatment (phone and computer access, business center facilities)
  • Extended program lengths (60 to 90 days or longer)

What luxury does not guarantee. Higher amenity levels do not inherently correspond to better clinical outcomes. The clinical quality of a program is determined by its treatment model, staff credentials, evidence-based practice use, and individualized treatment planning — not by the quality of the food or the thread count of the sheets. Some luxury programs offer excellent clinical care alongside their amenities; others emphasize comfort over clinical rigor.

When evaluating a luxury or specialized program, apply the same criteria used for any treatment facility: licensing status, accreditation, evidence-based practices, staff qualifications, and insurance or payment transparency.

For more on what to look for in luxury rehab and NJ-specific options, see: Luxury Rehab in New Jersey.

NJ Involuntary Commitment Laws

New Jersey has a legal mechanism for involuntary commitment to substance use treatment, though it is less widely known than equivalent laws in other states (such as Florida’s Marchman Act or Massachusetts’ Section 35).

NJSA 30:4-27.2 governs involuntary commitment in New Jersey. Key provisions:

  • A person may be involuntarily committed if they are deemed to be a danger to themselves or others as a result of substance use
  • The process typically begins with a screening at a designated screening center — each NJ county has at least one psychiatric emergency screening center
  • A clinical assessment determines whether criteria for involuntary commitment are met
  • Commitment is to a treatment facility, not a correctional facility — the goal is treatment, not punishment
  • Committed individuals retain legal rights including the right to counsel, the right to a hearing, and the right to periodic review of their commitment status
  • The standard commitment period is limited, with extensions requiring additional clinical justification and legal review

Important limitations. Involuntary commitment is a last resort, not a first-line intervention. It is appropriate only when a person meets specific clinical and legal criteria for danger. Research on the effectiveness of involuntary treatment is mixed — some studies show short-term benefits in stabilization, while others question whether coerced treatment produces durable recovery outcomes. Families considering this option should consult with both legal counsel and a clinical professional.

For the complete legal framework, process details, and what families should know, see: NJ Involuntary Commitment Laws.

Hotlines, Help Lines, and Crisis Resources

New Jersey residents have access to multiple free, confidential hotlines and crisis services for substance use issues.

State and Federal Hotlines

ResourceNumberHoursWhat It Provides
NJ Addictions Hotline1-844-276-277724/7Assessment, referrals to NJ treatment programs
NJ 2-1-121124/7Connections to local social services, treatment resources
SAMHSA National Helpline1-800-662-435724/7Free referrals, information about treatment, support groups
988 Suicide and Crisis Lifeline98824/7Crisis intervention for substance use and mental health emergencies
NJ Hopeline1-855-654-673524/7Peer support for NJ residents in emotional distress
Poison Control Center1-800-222-122224/7Information about substance exposures and overdose situations

County Crisis Services

Every New Jersey county operates a psychiatric emergency screening center (PESC) that provides crisis assessment and referral for substance use emergencies. These centers operate 24/7 and can initiate involuntary commitment proceedings when clinically warranted. Contact information for county PESCs is available through NJ 2-1-1 or the DMHAS website.

What to Expect When Calling

Hotline counselors are trained to conduct brief assessments, provide immediate safety planning, and connect callers to appropriate resources. Callers do not need insurance information to access these services. The NJ Addictions Hotline specifically can provide referrals to state-funded treatment for uninsured or underinsured callers.

For a comprehensive guide to all NJ crisis resources, see: Addiction Services Hotlines in NJ.

NJ Overdose Data and Monitoring

New Jersey maintains one of the more comprehensive overdose surveillance systems in the country, providing data that informs treatment planning, resource allocation, and policy decisions.

Key Data Sources

The NJ Overdose Prevention Dashboard (operated by the NJ Department of Health) provides near-real-time data on suspected drug-related overdose events. The dashboard includes county-level data, substance type breakdowns, and trend analyses.

The State Unintentional Drug Overdose Reporting System (SUDORS) is a CDC-funded program that collects detailed information on unintentional and undetermined drug overdose deaths. NJ participates in SUDORS and contributes data that supports both state and national analyses of overdose patterns.

What the Data Shows

New Jersey’s overdose data over the past decade reveal several key trends:

  • Fentanyl dominance. Synthetic opioids (primarily illicitly manufactured fentanyl) have become the leading cause of drug overdose death in New Jersey, overtaking both heroin and prescription opioids. Fentanyl is now detected in the majority of opioid-related overdose deaths in the state.
  • Polysubstance involvement. An increasing proportion of overdose deaths involve multiple substances — commonly fentanyl combined with stimulants (cocaine or methamphetamine), benzodiazepines, or alcohol.
  • Geographic concentration. While overdose deaths occur in every NJ county, rates are disproportionately concentrated in certain areas, including parts of Ocean, Camden, Essex, and Atlantic counties.
  • Demographic disparities. Overdose death rates vary by age, sex, and race/ethnicity. Recent NJ data have shown increasing rates among Black and Hispanic populations — a shift from earlier patterns where overdose deaths were disproportionately concentrated in white communities.

For detailed data analysis and how to interpret the state’s surveillance reports, see: NJ Overdose Dashboard and SUDORS Data.

When the Bed Isn’t Available: Navigating NJ Treatment Capacity

Capacity constraints in NJ’s treatment system are one of the most common — and least-discussed — barriers to care. Someone completes an assessment, receives a recommendation for inpatient detox or residential treatment, and then discovers the next available bed is 2 weeks out, or 4 weeks out, or in a county 90 minutes away. This section covers what actually happens at that moment and what options exist while waiting.

Where capacity pressure concentrates. Bed availability in NJ fluctuates by season, county, and service level. Fall and winter are peak-demand periods — post-holiday admissions surge in December and January particularly. Residential beds have the tightest constraints; detox centers typically have 24-72 hour windows; outpatient has the most headroom. Counties along the southern shore (Atlantic, Cape May, Cumberland) and the northwest (Sussex, Warren) have the fewest local beds and often require patients to travel to higher-density counties for residential care.

What the NJ Addictions Hotline actually does when a bed isn’t immediately available. The 1-844-276-2777 call center will: (a) identify bed availability across the state’s DMHAS-contracted facilities, (b) if no same-day placement is possible, schedule a clinical assessment with a county agency, (c) place the caller on a bed-availability list and follow up as openings occur, and (d) refer to interim services — outpatient counseling, recovery support meetings, peer specialist engagement — to reduce the risk of worsening during the wait. The hotline is a navigation tool, not a guaranteed same-day placement service.

Interim options while waiting for a residential or detox bed.

  • Ambulatory (outpatient) detox for lower-acuity withdrawal — several NJ programs offer medically-supervised outpatient withdrawal management that can bridge to residential once a bed is available. Not appropriate for alcohol or benzodiazepine withdrawal with seizure risk, but viable for opioids and mild-moderate alcohol cases.
  • Emergency department engagement for acute detox. NJ EDs increasingly have peer recovery specialists available via warm handoff. If withdrawal is medically dangerous (heavy alcohol, benzodiazepine, or severe opioid withdrawal with complications), an ED visit stabilizes the acute phase and initiates a warm-handoff to treatment placement.
  • Day IOP as a holding pattern. Starting IOP (9-15 hours/week) while on a residential wait list maintains clinical engagement and demonstrates readiness for care — sometimes accelerating residential placement when beds open because the patient has demonstrated stability through outpatient engagement.
  • NJ Syringe Access Programs as a touchpoint for actively using individuals during the wait — SAP staff can initiate buprenorphine in several NJ sites (same-day induction programs at several locations) which both stabilizes the person clinically and provides a trusted contact who can escalate if the situation worsens.
  • Recovery coaching and peer support during the wait period. NJ Peer Recovery Support Specialists engaged through county agencies can check in daily, problem-solve specific triggers, and maintain motivation during what is often a high-risk interval.

Single-case agreements and out-of-network placements. Covered in depth on the insurance and cost page, but relevant here: if insurance is in place and in-network NJ capacity is exhausted, the SCA mechanism allows placement at an out-of-network facility at in-network rates. This applies across state lines when clinically appropriate — some NJ residents are placed at well-regarded PA, NY, or CT programs via SCA when NJ capacity is saturated.

What to do at the emergency end. If someone is at immediate risk — acute overdose risk, active suicidal ideation with SUD, or medically dangerous withdrawal — the right move is the emergency department, not waiting for a bed. NJ EDs are mandated to stabilize and are increasingly wired to connect patients to SUD treatment directly from the ED via peer recovery specialists, MAT initiation, and warm-handoff protocols. The Emergency Department Peer Recovery program, funded through DMHAS, has expanded to most major NJ hospital EDs over the past several years.

Treatment in the NJ Correctional System and After Release

The intersection of addiction and incarceration is substantial in New Jersey — Bureau of Justice Statistics data indicate that roughly 65% of people in U.S. jails have an active substance use disorder, and the numbers in NJ are consistent with that pattern. The post-release period is the highest-risk window for overdose death anywhere in the addiction-treatment continuum, which makes treatment access during incarceration and in re-entry uniquely important. This section covers the NJ-specific landscape.

MAT access in NJ Department of Corrections facilities. New Jersey has expanded access to all three FDA-approved medications for opioid use disorder (buprenorphine, methadone, extended-release naltrexone) within state correctional facilities, though implementation varies by facility. The NJ DOC has been the subject of litigation and advocacy on MAT access, and a 2018 consent decree significantly expanded MAT availability. Specific facilities with established MAT programs include Northern State Prison, Central Reception and Assignment Facility, and Edna Mahan Correctional Facility for Women. County jails have inconsistent MAT access, with Essex, Camden, and Mercer County jails among those with the most developed programs.

Post-release overdose risk — and why. Tolerance decreases during incarceration. A person released after 6 months or longer has a dramatically reduced tolerance to opioids, and resumption of pre-incarceration dose levels produces frequent fatal overdose. Rhode Island research published in JAMA Internal Medicine found that providing all three MAT medications in corrections reduced post-release overdose deaths by 61%. NJ has been moving toward that model, though full statewide implementation is ongoing.

NJ Parole Addiction Services. Individuals on parole with identified SUD concerns receive addiction-services coordination through the State Parole Board’s Specialized Parole Services. This includes referral to treatment, MAT continuity for those started in-facility, drug testing, and peer recovery specialist support. Failure to engage with treatment can result in technical parole violations — which is contested by harm reduction advocates but remains current policy.

NJ Drug Court as an alternative to incarceration. Available in all 21 counties, NJ Drug Court diverts nonviolent drug-related offenses into structured treatment in lieu of a jail sentence. Requirements include 36+ months of supervised treatment, regular drug testing, court appearances, and demonstrated progress. Research cited by the NJ Administrative Office of the Courts indicates Drug Court graduates have recidivism rates 8-14 percentage points lower than comparable non-Drug-Court cases. Eligibility varies by offense; a criminal defense attorney familiar with NJ Drug Court can assess candidacy.

Re-entry resources specifically for SUD. Several NJ programs focus on the re-entry window:

  • Integrity House Re-Entry — the longest-running NJ re-entry program specifically serving formerly incarcerated individuals with SUD, with residential sites across the state.
  • NJ Re-entry Corporation (NJRC) — founded by former NJ Governor Jim McGreevey, provides case management, employment services, and treatment connection for returning citizens. Sites in Jersey City, Newark, Paterson, Kearny, and others.
  • County-level Specialized Re-entry Services — Essex, Hudson, Camden, and Mercer counties have formal re-entry programs with SUD-specific tracks.
  • Peer Recovery Specialists trained for re-entry — DMHAS has funded a specific peer workforce trained to support people in the first 90 days post-release, which research shows is the highest-risk window.

Medicaid and healthcare coverage in the re-entry window. A persistent gap has been Medicaid coverage continuity: NJ FamilyCare benefits are typically suspended during incarceration and re-activated on release, but there is often a lag of days to weeks before coverage is fully restored. NJ DHS has implemented a pre-release Medicaid application process to reduce this gap, and the state operates transitional coverage for specific populations. For a person leaving incarceration with SUD, connecting with a county re-entry caseworker before release is the single most impactful move — it shortens the coverage gap, schedules a first post-release provider visit, and initiates MAT continuity.

Naloxone at release. NJ DOC and many county jails now provide naloxone kits at release as part of overdose-prevention protocols. For someone being released to a household where another person is in active use, or for someone at personal overdose risk, having naloxone on hand is critical during the post-release tolerance-reset window.

NJ-Specific Programs: X-Waiver, IRTS, MICA

New Jersey has several specialized treatment programs that may not be familiar to residents or even to providers from other states.

MICA programs (Mentally Ill Chemically Addicted) provide integrated treatment for individuals with co-occurring serious mental illness and substance use disorders. MICA is a NJ-specific designation for programs that meet enhanced staffing and programming requirements for this population. For more context on dual diagnosis treatment, see our pillar on mental health and dual diagnosis.

IRTS (Integrated Residential Treatment Services) provides longer-term residential care for individuals with co-occurring disorders who need extended stabilization. IRTS programs bridge the gap between acute residential treatment and independent living.

DATA-waiver / X-Waiver changes. Historically, physicians needed a special waiver (the “X-waiver”) to prescribe buprenorphine for opioid use disorder. As of January 2023, the X-waiver requirement was eliminated nationally through legislation, meaning any DEA-registered practitioner with a standard controlled substance license can now prescribe buprenorphine. This significantly expanded access to medication-assisted treatment in New Jersey, particularly in primary care settings.

For detailed descriptions of NJ-specific treatment programs, see: NJ Treatment Programs: X-Waiver, IRTS, MICA.

Consumer Protection: Rehabs Under Investigation

New Jersey’s treatment landscape, like that of every state, includes facilities that have faced regulatory scrutiny, licensing actions, or investigations. Consumers have the right to verify a facility’s regulatory standing before entering treatment.

How to Verify a Facility

  • Check DMHAS licensing status. The NJ Division of Mental Health and Addiction Services maintains records of licensed facilities, including any active enforcement actions.
  • Search for accreditation. CARF and the Joint Commission both provide online directories where consumers can verify whether a facility holds current accreditation.
  • Review the NJ Attorney General’s consumer complaints. The Division of Consumer Affairs receives complaints about healthcare providers, including treatment facilities.
  • Search state court records. Lawsuits involving treatment facilities (malpractice, wrongful death, fraud) may be searchable through NJ court records.

What Red Flags Look Like

Without disparaging any specific facility, the following patterns should prompt additional investigation:

  • A facility that cannot or will not provide its DMHAS license number
  • Marketing that guarantees specific outcomes or recovery rates
  • High-pressure admissions tactics, including same-day admission pressure
  • Facilities that waive all insurance copays or deductibles (this can indicate insurance fraud)
  • Programs that lack any accreditation and have no licensed clinical staff listed on their website

For more on consumer protection and how to evaluate treatment facility credibility, see: NJ Rehabs Under Investigation.

Veterans Services in New Jersey

Veterans face elevated rates of substance use disorders, driven by factors including combat-related PTSD, traumatic brain injury, chronic pain management with opioids, military culture around alcohol use, and the challenges of transition to civilian life.

VA Addiction Treatment in NJ

The VA New Jersey Health Care System operates treatment programs at its East Orange and Lyons campuses, including:

  • Inpatient substance use disorder treatment
  • Outpatient addiction treatment (individual and group)
  • Medication-assisted treatment (buprenorphine, naltrexone, methadone through opioid treatment programs)
  • PTSD-SUD integrated treatment programs
  • Residential rehabilitation programs

NJ Veteran-Specific Resources

  • NJ Department of Military and Veterans Affairs provides referrals to state and federal treatment resources for veterans
  • Veterans Crisis Line: dial 988, then press 1 — 24/7 crisis intervention specifically for veterans
  • Vet Centers — community-based counseling centers operated by the VA that provide readjustment counseling, including substance use counseling, at no cost. New Jersey has Vet Centers in multiple locations.
  • NJ Veteran Haven programs provide transitional housing for homeless veterans, with connections to substance use treatment

Eligibility and Access

Not all veterans are eligible for full VA healthcare benefits. Eligibility depends on discharge status, length of service, service-connected disabilities, and income level. Veterans with service-connected conditions, including PTSD and substance use disorders related to military service, generally receive priority access. The VA’s eligibility determination process can be navigated through enrollment coordinators at any VA facility.

For the complete guide to veteran addiction treatment benefits and NJ-specific resources, see: Veterans Benefits for Addiction Treatment in NJ.

NJ Medicaid and Insurance Coverage

NJ FamilyCare (New Jersey’s Medicaid program) covers substance use disorder treatment including:

  • Medical detoxification
  • Residential treatment (short-term and long-term)
  • Partial hospitalization programs (PHP)
  • Intensive outpatient programs (IOP)
  • Standard outpatient treatment
  • Medication-assisted treatment (methadone, buprenorphine, naltrexone)
  • Recovery support services

Under the Mental Health Parity and Addiction Equity Act (MHPAEA), commercial insurance plans are required to provide coverage for substance use disorder treatment that is no more restrictive than coverage for medical and surgical conditions. In practice, this means that insurance plans cannot impose separate deductibles, more restrictive prior authorization requirements, or lower visit limits for addiction treatment compared to other medical conditions.

NJ residents who are uninsured or underinsured can access treatment through the county behavioral health system, which administers state-funded treatment slots. The NJ Addictions Hotline (1-844-276-2777) can assist with determining eligibility for publicly funded treatment.

For broader coverage of insurance and cost issues, see our pillar on insurance and cost of addiction treatment.

Frequently Asked Questions

How do I find a treatment center near me in NJ? Start with the NJ Addictions Hotline (1-844-276-2777) for a free assessment and referral, or dial 211 for NJ 2-1-1. SAMHSA’s treatment locator (findtreatment.gov) also allows searching by ZIP code with filters for treatment type, payment options, and specializations.

Does NJ Medicaid cover rehab? Yes. NJ FamilyCare covers detoxification, residential treatment, outpatient treatment, and medication-assisted treatment. Coverage details and authorization requirements vary by service type. Contact NJ FamilyCare or the provider directly to verify specific coverage.

Can someone be forced into rehab in New Jersey? New Jersey law (NJSA 30:4-27.2) allows for involuntary commitment to treatment under specific circumstances — primarily when a person is deemed a danger to themselves or others due to substance use. The process requires a clinical screening and legal review. It is not a simple process and is intended as a last resort.

What is the NJ Addictions Hotline? The NJ Addictions Hotline (1-844-276-2777) is a state-operated, free, confidential helpline that provides clinical assessment and referrals to treatment programs. It operates 24 hours a day, 7 days a week, and can connect callers to both state-funded and private treatment options.

Are there free rehab programs in New Jersey? Yes. State-funded treatment is available through the county behavioral health system for individuals who are uninsured or underinsured. Some nonprofit treatment organizations also provide low-cost or sliding-scale treatment. The NJ Addictions Hotline can help identify available state-funded treatment slots.

What should I do if I suspect a NJ treatment facility is fraudulent? Contact the NJ Division of Consumer Affairs to file a complaint. You can also verify a facility’s licensing status through DMHAS. If you believe insurance fraud is occurring, the NJ Department of Banking and Insurance accepts fraud reports.

Topics in This Guide

This pillar page is part of the NJ Resources content silo on NJ Addiction Centers. For deeper coverage of each topic, explore the dedicated guides below:

For related topics across other silos, see:

Looking for treatment options in your area? We can help point you in the right direction. (888) 699-0742 — or request a callback.